D. Vijay Pharma Private Limited
D. Vijay Pharma Private Limited
Send Email
Send SMS
Search

Home » Our Products » Anti Cancer Tablets And Capsules


Anti Cancer Tablets And Capsules

Pioneers in the industry, we offer lynparza ( olaparib ) 150mg tablets and xeljanz 5 mg tablet from India.

Lynparza ( Olaparib ) 150Mg Tablets

REQUEST CALLBACK

Lynparza ( Olaparib ) 150Mg Tablets
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 35,500 / StripGet Latest Price

Product Details:
Minimum Order Quantity1 Strip
BrandLynparza 150mg tablets
Drug NameOlaparib
Dose/Strength150Mg
Usage/ApplicationPersonal
Packaging Type8 Tablets per strip
Packaging SizeStrip

Lynparza 150 mg film-coated tablets. Each film-coated tablet contains 150 mg olaparib. Excipient with known effect: This medicinal product contains 0.24 mg.

Lynparza (olaparib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Lynparza is used to treat advanced ovarian cancer in women with a certain abnormal inherited gene who have responded to platinum chemotherapy.

Additional Information:

  • Item Code: 9666
  • Delivery Time: Depends on location
  • Yes! I am interested

    Xeljanz 5 mg Tablet

    REQUEST CALLBACK

    Xeljanz 5 mg Tablet
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 18,000 / BottleGet Latest Price

    Product Details:
    Minimum Order Quantity1 Bottle
    CompositionTofacitinib 5 mg
    FormTablet
    Packaging Size60 Tablets
    Usage/ApplicationRheumatoid Arthiritis
    Brand NameXeljanz 5 Mg Tablet
    Dosage5 Mg

    Tofacitinib (Xeljanz) is an oral, small molecule drug used to treat adults with moderately to severely active rheumatoid arthritis (RA) in which methotrexate did not work well. Tofacitinib works by blocking the body’s production of enzymes called Janus kinases (JAKs) and psoriatic arthritis. JAKs play a role in joint inflammation in RA, which can cause pain, swelling, and stiffness.

    Tofacitinib is a pill that is taken either as 5 mg twice per day (Xeljanz®) or as 11 mg once per day (Xeljanz XR®). You may take tofacitinib tablets with or without food. People with moderate to severe renal impairment or moderate hepatic impairment should take only one 5 mg tablet per day. Tofacitinib may be used alone or in combination with methotrexate or other DMARDs. Tofacitinib should not be given in combination with another biologic drug or other potent immunosuppressants such as azathioprine or mycophenolate. Some patients will start to see improvement within a few weeks, but it may take several months to take full effect. Blood tests will be used to monitor for increases in cholesterol or liver enzymes and for reductions in blood cell counts while taking tofacitinib.

    SIDE EFFECTS:-

    Tofacitinib can lower the ability of your immune system to fight infections. If you develop symptoms of an infection while using this medication, you should stop it and contact your doctor. The most common side effects of tofacitinib are upper respiratory tract infections, headache, diarrhea, and nasopharyngitis. All patients should be tested for tuberculosis before starting on tofacitinib. Patients should also be screened for hepatitis B and C prior to starting tofacitinib, since this medication may increase risk of reactivation of these infections. Tofacitinib has been associated with increased cholesterol levels in some patients, and should be periodically monitored. If your cholesterol level becomes too high, it is possible you may need to start taking a medication to lower it. A rare complication seen with tofacitinib use in clinical trials was bowel perforation, or a hole in the bowel wall. If you have a history or diverticulitis or develop abdominal pain or bloody bowel movements while taking tofacitinib, you should notify your doctor immediately. Lymphoma and other malignancies have been observed in patients treated with tofacitinib. Epstein Barr Virus-associated post-transplant lymphoproliferative disorder has been observed at an increased rate in renal transplant patients treated with tofacitinib and concomitant immunosuppressive medications.


    Additional Information:

  • Delivery Time: depends on location
  • Yes! I am interested

     
    X


    Explore More Products

    Contact via E-mail
    Contact via SMS
    Jimit Bhinde (Marketing Manager)
    D. Vijay Pharma Private Limited
    Unit No. 11, Shilpin Center, GD Ambedkar Road, Dadar East
    Mumbai - 420031, Maharashtra, India
    Call Us: 
    Call Response Rate: 79%
    Share Us :
    F G T L



    Home  |   Profile   |  Our Products  |  Site Map  |   Contact Us

    © D. Vijay Pharma Private Limited. All Rights Reserved (Terms of Use)
    Developed and Managed by IndiaMART InterMESH Limited

    D. Vijay Pharma Private Limited